HLA-A — Major Histocompatibility Complex Class I A

Introduction

HLA-A — Major Histocompatibility Complex Class I A
**Gene Symbol**	HLA-A
**Full Name**	Major Histocompatibility Complex Class I A
**Chromosomal Location**	6p21.3
**NCBI Gene ID**	3105
**Ensembl ID**	ENSG00000206503
**UniProt ID**	P01890
**OMIM**	142800
Allele	Association
HLA-A*02:01	Risk allele
HLA-A*03:01	Risk allele
HLA-A*24:02	Protective
Allele	Caucasians
A*02:01	~30%
A*03:01	~20%
A*24:02	~10%
A*01:01	~15%
Associated Diseases	Als, Alzheimer, Lymphoma, Ms
KG Connections	36 edges

HLA-A (Major Histocompatibility Complex Class I A) is a key gene located on chromosome 6p21.3 within the human leukocyte antigen (HLA) complex. It encodes the alpha chain of the HLA class I molecule, a cell surface glycoprotein essential for immune surveillance and antigen presentation to CD8+ cytotoxic T-lymphocytes^{1The HLA system2000 · N Engl J Med · PMID 10974132Open reference2HLA complex: from gene to function2009 · Immunogenetics · PMID 19301028Open reference}.

HLA class I molecules are expressed on the surface of virtually all nucleated cells and present endogenously synthesized peptide antigens to CD8+ T-cells. This process is fundamental to immune defense against intracellular pathogens ( viruses and some bacteria) and malignant transformation. Beyond this classical function, increasing evidence implicates HLA class I molecules in broader biological processes, including immune regulation in the central nervous system (CNS)^{3HLA class I and immune regulation in the brain2010 · Prog Mol Biol Transl Sci · PMID 20699246Open reference4HLA class I molecules couple to multiple receptor tyrosine kinases2013 · J Immunol · PMID 24227734Open reference}.

The HLA-A gene is extraordinarily polymorphic, with thousands of documented alleles across global populations. This diversity has significant implications for disease susceptibility, transplant matching, and therapeutic response^{5The HLA system: genetics and disease association2007 · Transfusion · PMID 17580788Open reference}.

Gene Overview

Molecular Biology

Gene Structure

The HLA-A gene spans approximately 2.6 kb and comprises 8 exons:

• Exon 1: 5’ untranslated region and signal peptide

• Exons 2-4: Encoding the three extracellular domains (α1, α2, α3)

• Exon 5: Transmembrane domain

• Exon 6: Cytoplasmic tail

• Exon 7: 3’ untranslated region

Protein Structure

HLA-A encodes a transmembrane glycoprotein consisting of:

1. Heavy chain (~45 kDa): The polymorphic α-chain encoded by HLA-A

2. β2-microglobulin (~12 kDa): Non-polymorphic light chain, required for surface expression

3. Peptide binding groove: Forms from the α1 and α2 domains, accommodates 8-10 amino acid peptides

The peptide binding groove has pockets (B and F being most important) that determine peptide binding specificity. Different HLA-A alleles have distinct peptide binding preferences.

Expression Pattern

HLA-A is expressed:

• Constitutively: All nucleated cells

• Inducible: Upregulated by IFN-γ, TNF-α, and other cytokines

• High expression: Immune cells (lymphocytes, monocytes)

• Brain expression: Neurons, astrocytes, microglia

Function

Classical MHC Class I Function

The primary function of HLA-A involves antigen presentation:

Peptide Processing and Loading

1. Intracellular proteins are degraded by the proteasome

2. Peptides are transported to the ER by TAP (transporter associated with antigen processing)

3. Peptides are loaded onto HLA-A molecules with the assistance of tapasin

4. The peptide-HLA-A complex is transported to the cell surface

Immune Recognition

1. Surface HLA-A-peptide complexes are recognized by CD8+ T-cell receptors

2. This triggers cytotoxic T lymphocyte (CTL) activation

3. Activated CTLs can eliminate the presenting cell

Non-Classical Functions

HLA-A has additional functions beyond antigen presentation^{4HLA class I molecules couple to multiple receptor tyrosine kinases2013 · J Immunol · PMID 24227734Open reference6The emerging role of HLA class I in neurodegenerative disease2017 · Nat Rev Neurol · PMID 28361916Open reference}:

Interaction with NK Cells

• HLA-A interacts with killer cell immunoglobulin-like receptors (KIRs)

• Can inhibit NK cell cytotoxicity in some contexts

Signaling Functions

• HLA-A can signal through multiple receptors

• Modulates cell survival and proliferation

CNS Functions

• Regulation of neuronal development

• Synaptic plasticity modulation

• Neuroprotection

Disease Associations

Multiple Sclerosis

HLA-A alleles have been studied in multiple sclerosis^{7HLA in multiple sclerosis and other autoimmune diseases2002 · Brain · PMID 11872614Open reference}:

The HLA region contributes significantly to MS genetic risk, with HLA-DRB1*15:01 being the strongest individual effect.

Parkinson’s Disease

HLA-A and the broader HLA class I region have been implicated in Parkinson’s disease susceptibility^{8Microglial HLA-DR and CD4 T cells in Parkinson's disease2018 · Acta Neuropathol · PMID 29594288Open reference9HLA-DRB1 and Parkinson's disease risk: a meta-analysis2019 · Neurology · PMID 30626653Open reference2HLA complex: from gene to function2009 · Immunogenetics · PMID 19301028Open reference}0:

Key Findings

• HLA region polymorphisms influence PD risk

• HLA-DRB1 variants show stronger associations than HLA-A

• Some HLA-A alleles may modify disease progression

Proposed Mechanisms

1. Alpha-synuclein presentation: HLA-A may present α-syn fragments to T-cells^{2HLA complex: from gene to function2009 · Immunogenetics · PMID 19301028Open reference}1

2. Microglial activation: HLA class I modulates microglial responses

3. Autoimmunity: Potential for α-syn-specific T-cell responses

4. Neuroinflammation: HLA class I influences inflammatory responses

Alzheimer’s Disease

HLA class I molecules have complex roles in Alzheimer’s disease

^{2HLA complex: from gene to function2009 · Immunogenetics · PMID 19301028Open reference}2:

Current Understanding

• Altered HLA class I expression in AD brain

• Potential roles in amyloid clearance

• Neuroinflammation modulation

Therapeutic Implications

• HLA class I-based immunotherapy approaches

• Modulation of antigen presentation pathways

Other Neurological Conditions

• Narcolepsy: HLA-DQB1*06:02 is primary association, HLA-A modifies risk

• Amyotrophic Lateral Sclerosis (ALS): Some HLA associations reported

• Guillain-Barré syndrome: Strong HLA associations

Non-Neurological Diseases

• Autoimmune disorders: Type 1 diabetes, rheumatoid arthritis, SLE

• Infectious disease: HIV progression, hepatitis outcomes

• Transplantation: Graft rejection, graft-versus-host disease

Genetic Polymorphism

Major Alleles

The HLA-A gene has thousands of documented alleles:

Common Alleles by Population

Allele Groups

• A*02: Most common group globally

• A*03: Common in Europeans

• A*24: Common in East Asians

• A*01: Variable by population

Therapeutic Implications

Transplantation

HLA-A matching is critical for:

• Solid organ transplantation

• Hematopoietic stem cell transplantation

• Reducing graft rejection risk

Immunotherapy

HLA-A is relevant for^{2HLA complex: from gene to function2009 · Immunogenetics · PMID 19301028Open reference}3:

• Cancer immunotherapy: Peptide vaccines targeting HLA-A

• Adoptive T-cell therapy

• Checkpoint inhibitor response

Neurodegeneration

Potential therapeutic approaches include:

• Modulating HLA class I expression

• Targeting specific antigen presentation pathways

• Immunomodulatory strategies

Brain-Specific Considerations

CNS Immune Privilege

The brain has specialized immune regulation:

• Blood-brain barrier: Limits immune cell entry

• Microglial surveillance: Resident immune cells

• Limited classical antigen presentation: Compared to peripheral immune

HLA in the Normal Brain

In healthy CNS:

• Low basal HLA class I expression

• Upregulated in disease states

• Roles in development and plasticity

HLA in Disease

Disease-associated changes include^{2HLA complex: from gene to function2009 · Immunogenetics · PMID 19301028Open reference}4:

• Increased microglial HLA expression

• Altered antigen presentation

• T-cell infiltration in some conditions

Epigenetic Regulation

DNA Methylation

HLA-A expression is subject to epigenetic regulation:

• Promoter methylation: Can repress HLA-A expression in tumors

• Tissue-specific patterns: Distinct methylation in immune vs. non-immune tissues

• Disease-associated changes: Altered methylation in neurodegenerative conditions

Histone Modifications

Chromatin states affect HLA-A:

• Active marks: H3K27ac associated with expression

• Repressive marks: H3K27me3 in silenced contexts

• Enhancer activities: Distal regulatory elements

Non-coding RNAs

microRNAs modulate HLA-A:

• miR-148a: Targets HLA-A 3’UTR

• miR-568: Downregulates HLA class I

• Let-7 family: Multiple targets in antigen presentation

Molecular Mechanisms in Neurodegeneration

ER Stress Response

HLA-A folding occurs in the endoplasmic reticulum:

1. Protein synthesis: Heavy chain translation in ER

2. Quality control: Calreticulin/calnexin system

3. peptide loading: TAP-mediated peptide transport

4. Surface expression: Golgi processing and trafficking

ER stress affects HLA-A processing in neurodegeneration.

Autophagy Interplay

Autophagy and HLA-A intersect:

• Cross-presentation: Autophagy delivers antigens to HLA class I

• IFN-γ effects: Autophagy required for optimal presentation

• Disease relevance: Altered autophagy in neurodegeneration

Neuroimmune Signaling

The neuroimmune axis involves HLA-A:

• Microglial activation: Triggered by antigen presentation

• T-cell infiltration: CD8+ T-cells in PD/AD brain

• Cytokine effects: IFN-γ modulates HLA expression

Research Directions

Current Areas of Investigation

1. Genetic studies: Population-specific HLA effects

2. Functional studies: Mechanism of HLA-associated risk

3. Therapeutic development: HLA-targeting approaches

4. Biomarkers: HLA as disease biomarker

5. Single-cell analysis: Cell-type specific expression

Future Directions

• Personalized medicine applications

• Gene therapy approaches

• Immunomodulation strategies

• Epigenetic therapies

• CAR-T cell approaches for neurodegeneration

Interaction Networks

Receptor Interactions

HLA-A interacts with multiple receptors:

1. T-cell Receptor (TCR): Primary interaction

   • CD8+ T-cell recognition

   • Activation of cytotoxic response

2. Killer Cell Immunoglobulin-like Receptors (KIRs)

   • NK cell regulation

   • Inhibition or activation

3. CD8 Co-receptor

   • Enhances TCR engagement

   • Required for optimal signaling

Peptide Presentation

HLA-A presents diverse peptides:

• Viral peptides: From infected cells

• Tumor antigens: Cancer-specific peptides

• Self-peptides: Normal cellular proteins

• Mutated peptides: Cancer-associated variants

Clinical Considerations

HLA Matching

Transplantation requires HLA-A matching:

1. Donor-recipient matching: Minimize rejection

2. Desensitization protocols: For mismatched transplants

3. Virtual crossmatching: Pre-transplant assessment

Disease associations

Beyond neurodegeneration:

• Type 1 Diabetes: Strong HLA-DR association

• Rheumatoid Arthritis: HLA-DR specific

• Systemic Lupus Erythematosus: Multiple loci

• Celiac Disease: HLA-DQ specific

Research Methods

Detection Methods

• Serology: Traditional typing

• Sequence-based typing (SBT): DNA sequencing

• Flow cytometry: Cell surface expression

• Mass spectrometry: Peptide identification

Animal Models

• Transgenic mice: HLA-A expression

• Knockout models: Loss of function studies

• Humanized mice: Immune system models

Summary

HLA-A represents a critical intersection between adaptive immunity and neurodegenerative disease. Its role in antigen presentation, immune regulation in the CNS, and genetic associations with disease risk make it an important target for understanding neurodegeneration. Key implications include:

• Disease risk: HLA alleles modify neurodegenerative risk

• Immune modulation: Class I pathways in neuroinflammation

• Therapeutic potential: Targeting antigen presentation

• Biomarker development: HLA as disease marker

Further research into HLA class I biology will provide insights into neurodegenerative disease mechanisms and potential therapeutic approaches.

See Also

• Major Histocompatibility Complex

• Multiple Sclerosis

• Parkinson’s Disease

• Alzheimer’s Disease

• Neuroinflammation

• Microglia

External Links

• NCBI Gene: HLA-A

• UniProt: HLA-A

• IMGT/HLA Database

• PubMed